Qi Tang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 17

Top Topics

Cognitive Decline

Top Venues

Nature reviews. Drug discovery

Nucleic acids research

Nature biotechnology

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Qi Tang, Anastasia Khvorova
RNAi-based drug design: considerations and future directions. Nature reviews. Drug discovery (2024)
Ken Yamada, Vignesh Narayan Hariharan, Jillian Caiazzi, Rachael Miller, Chantal M Ferguson, Ellen Sapp, Hassan H Fakih, Qi Tang, Nozomi Yamada, Raymond C Furgal, Joseph D Paquette, Annabelle Biscans, Brianna M Bramato, Nicholas McHugh, Ashley Summers, Clemens Lochmann, Bruno M D C Godinho, Samuel Hildebrand, Samuel O Jackson, Dimas Echeverria, Matthew R Hassler, Julia F Alterman, Marian DiFiglia, Neil Aronin, Anastasia Khvorova
Enhancing siRNA efficacy in vivo with extended nucleic acid backbones. Nature biotechnology (2024)
Jillian Belgrad, Qi Tang, Samuel R Hildebrand, Ashley Summers, Ellen Sapp, Dimas Echeverria Moreno, Daniel O'Reilly, Eric Luu, Brianna Bramato, Sarah Allen, David Cooper, Julia F Alterman, Ken Yamada, Neil Aronin, Marian DiFiglia, Anastasia Khvorova
A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system. Nucleic acids research 52 (11) (2024)
Jillian Belgrad, Qi Tang, Samuel R Hildebrand, Ashley Summers, Ellen Sapp, Dimas Echeverria Moreno, Daniel O'Reilly, Eric Luu, Brianna Bramato, Sarah Allen, David Cooper, Julia F Alterman, Ken Yamada, Neil Aronin, Marian DiFiglia, Anastasia Khvorova
A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system. Nucleic acids research (2024)
Jillian Belgrad, Qi Tang, Samuel R Hildebrand, Ashley Summers, Ellen Sapp, Dimas Echeverria Moreno, Daniel O'Reilly, Eric Luu, Brianna Bramato, Sarah Allen, David Cooper, Julia F Alterman, Ken Yamada, Neil Aronin, Marian DiFiglia, Anastasia Khvorova
A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system. Nucleic acids research 52 (11) (2024)
Jillian Belgrad, Qi Tang, Samuel R Hildebrand, Ashley Summers, Ellen Sapp, Dimas Echeverria Moreno, Daniel O'Reilly, Eric Luu, Brianna Bramato, Sarah Allen, David Cooper, Julia F Alterman, Ken Yamada, Neil Aronin, Marian DiFiglia, Anastasia Khvorova
A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system. Nucleic acids research 52 (11) (2024)
Jillian Belgrad, Qi Tang, Samuel R Hildebrand, Ashley Summers, Ellen Sapp, Dimas Echeverria Moreno, Daniel O'Reilly, Eric Luu, Brianna Bramato, Sarah Allen, David Cooper, Julia F Alterman, Ken Yamada, Neil Aronin, Marian DiFiglia, Anastasia Khvorova
A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system. Nucleic acids research (2024)
Ken Yamada, Vignesh Narayan Hariharan, Jillian Caiazzi, Rachael Miller, Chantal M Ferguson, Ellen Sapp, Hassan H Fakih, Qi Tang, Nozomi Yamada, Raymond C Furgal, Joseph D Paquette, Annabelle Biscans, Brianna M Bramato, Nicholas McHugh, Ashley Summers, Clemens Lochmann, Bruno M D C Godinho, Samuel Hildebrand, Samuel O Jackson, Dimas Echeverria, Matthew R Hassler, Julia F Alterman, Marian DiFiglia, Neil Aronin, Anastasia Khvorova
Enhancing siRNA efficacy in vivo with extended nucleic acid backbones. Nature biotechnology (2024)
Qi Tang, Anastasia Khvorova
RNAi-based drug design: considerations and future directions. Nature reviews. Drug discovery 23 (5) (2024)
Jillian Belgrad, Qi Tang, Samuel R Hildebrand, Ashley Summers, Ellen Sapp, Dimas Echeverria Moreno, Daniel O'Reilly, Eric Luu, Brianna Bramato, Sarah Allen, David Cooper, Julia F Alterman, Ken Yamada, Neil Aronin, Marian DiFiglia, Anastasia Khvorova
A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system. Nucleic acids research (2024)
Qi Tang, Anastasia Khvorova
RNAi-based drug design: considerations and future directions. Nature reviews. Drug discovery 23 (5) (2024)
Qi Tang, Anastasia Khvorova
RNAi-based drug design: considerations and future directions. Nature reviews. Drug discovery (2024)
Qi Tang, Anastasia Khvorova
RNAi-based drug design: considerations and future directions. Nature reviews. Drug discovery 23 (5) (2024)
Qi Tang, Anastasia Khvorova
RNAi-based drug design: considerations and future directions. Nature reviews. Drug discovery 23 (5) (2024)
Qi Tang, Anastasia Khvorova
RNAi-based drug design: considerations and future directions. Nature reviews. Drug discovery 23 (5) (2024)
Vignesh Narayan Hariharan, Jillian Caiazzi, Rachael Miller, Chantal M Ferguson, Ellen Sapp, Hassan Fakih, Qi Tang, Nozomi Yamada, Raymond Furgal, Joseph Paquette, Brianna Bramato, Nicholas McHugh, Ashley Summers, Clemens Lochmann, Bruno M D C Godinho, Samuel Hildebrand, Dimas Echeverria, Matthew R Hassler, Julia F Alterman, Marian DiFiglia, Neil Aronin, Anastasia Khvorova, Ken Yamada
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy in vivo. Research square (2023)
Qi Tang, Hassan H Fakih, Mohammad Zain Ui Abideen, Samuel R Hildebrand, Khashayar Afshari, Katherine Y Gross, Jacquelyn Sousa, Allison S Maebius, Christina Bartholdy, Pia Pernille Søgaard, Malene Jackerott, Vignesh Narayan Hariharan, Ashley Summers, Xueli Fan, Ken Okamura, Kathryn R Monopoli, David A Cooper, Dimas Echeverria, Brianna Bramato, Nicholas McHugh, Raymond C Furgal, Karen Dresser, Sarah J Winter, Annabelle Biscans, Jane Chuprin, Nazgol-Sadat Haddadi, Shany Sherman, Ümmügülsüm Yıldız-Altay, Mehdi Rashighi, Jillian M Richmond, Claire Bouix-Peter, Carine Blanchard, Adam Clauss, Julia F Alterman, Anastasia Khvorova, John E Harris
Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin. Nature communications 14 (1) (2023)